Clinical cases of BsAb-induced T cell exhaustion have been recorded, with a blinatumomab-resistant ALL patient displaying an increase of PD-L1-expressing B-precursor ALL cells (224). The gene discussed is CD274; the disease is acute lymphoblastic leukemia.